190 related articles for article (PubMed ID: 24236457)
1. Chemoprevention gene therapy (CGT) of pancreatic cancer using perillyl alcohol and a novel chimeric serotype cancer terminator virus.
Sarkar S; Azab B; Quinn BA; Shen X; Dent P; Klibanov AL; Emdad L; Das SK; Sarkar D; Fisher PB
Curr Mol Med; 2014 Jan; 14(1):125-40. PubMed ID: 24236457
[TBL] [Abstract][Full Text] [Related]
2. Chemoprevention by perillyl alcohol coupled with viral gene therapy reduces pancreatic cancer pathogenesis.
Lebedeva IV; Su ZZ; Vozhilla N; Chatman L; Sarkar D; Dent P; Athar M; Fisher PB
Mol Cancer Ther; 2008 Jul; 7(7):2042-50. PubMed ID: 18645014
[TBL] [Abstract][Full Text] [Related]
3. Therapy of prostate cancer using a novel cancer terminator virus and a small molecule BH-3 mimetic.
Sarkar S; Quinn BA; Shen XN; Dash R; Das SK; Emdad L; Klibanov AL; Wang XY; Pellecchia M; Sarkar D; Fisher PB
Oncotarget; 2015 May; 6(13):10712-27. PubMed ID: 25926554
[TBL] [Abstract][Full Text] [Related]
4. Chemoprevention gene therapy (CGT): novel combinatorial approach for preventing and treating pancreatic cancer.
Sarkar S; Azab BM; Das SK; Quinn BA; Shen X; Dash R; Emdad L; Thomas S; Dasgupta S; Su ZZ; Wang XY; Sarkar D; Fisher PB
Curr Mol Med; 2013 Aug; 13(7):1140-59. PubMed ID: 23157679
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of in vitro pancreatic cancer cell growth inhibition by melanoma differentiation-associated gene-7/interleukin-24 and perillyl alcohol.
Lebedeva IV; Su ZZ; Vozhilla N; Chatman L; Sarkar D; Dent P; Athar M; Fisher PB
Cancer Res; 2008 Sep; 68(18):7439-47. PubMed ID: 18768668
[TBL] [Abstract][Full Text] [Related]
6. Eradication of therapy-resistant human prostate tumors using a cancer terminator virus.
Sarkar D; Lebedeva IV; Su ZZ; Park ES; Chatman L; Vozhilla N; Dent P; Curiel DT; Fisher PB
Cancer Res; 2007 Jun; 67(11):5434-42. PubMed ID: 17545625
[TBL] [Abstract][Full Text] [Related]
7. Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) improves therapeutic efficacy in low CAR prostate cancer cells.
Dash R; Dmitriev I; Su ZZ; Bhutia SK; Azab B; Vozhilla N; Yacoub A; Dent P; Curiel DT; Sarkar D; Fisher PB
Cancer Gene Ther; 2010 Jul; 17(7):447-56. PubMed ID: 20150932
[TBL] [Abstract][Full Text] [Related]
8. Reversing translational suppression and induction of toxicity in pancreatic cancer cells using a chemoprevention gene therapy approach.
Sarkar S; Quinn BA; Shen X; Dent P; Das SK; Emdad L; Sarkar D; Fisher PB
Mol Pharmacol; 2015 Feb; 87(2):286-95. PubMed ID: 25452327
[TBL] [Abstract][Full Text] [Related]
9. Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) in combination with the Apogossypol derivative BI-97C1 (Sabutoclax) improves therapeutic efficacy in low CAR colorectal cancer cells.
Azab B; Dash R; Das SK; Bhutia SK; Shen XN; Quinn BA; Sarkar S; Wang XY; Hedvat M; Dmitriev IP; Curiel DT; Grant S; Dent P; Reed JC; Pellecchia M; Sarkar D; Fisher PB
J Cell Physiol; 2012 May; 227(5):2145-53. PubMed ID: 21780116
[TBL] [Abstract][Full Text] [Related]
10. Enhanced prostate cancer gene transfer and therapy using a novel serotype chimera cancer terminator virus (Ad.5/3-CTV).
Azab BM; Dash R; Das SK; Bhutia SK; Sarkar S; Shen XN; Quinn BA; Dent P; Dmitriev IP; Wang XY; Curiel DT; Pellecchia M; Reed JC; Sarkar D; Fisher PB
J Cell Physiol; 2014 Jan; 229(1):34-43. PubMed ID: 23868767
[TBL] [Abstract][Full Text] [Related]
11. Enhancing mda-7/IL-24 therapy in renal carcinoma cells by inhibiting multiple protective signaling pathways using sorafenib and by Ad.5/3 gene delivery.
Eulitt PJ; Park MA; Hossein H; Cruikshanks N; Yang C; Dmitriev IP; Yacoub A; Curiel DT; Fisher PB; Dent P
Cancer Biol Ther; 2010 Dec; 10(12):1290-305. PubMed ID: 20948318
[TBL] [Abstract][Full Text] [Related]
12. Induction of reactive oxygen species renders mutant and wild-type K-ras pancreatic carcinoma cells susceptible to Ad.mda-7-induced apoptosis.
Lebedeva IV; Su ZZ; Sarkar D; Gopalkrishnan RV; Waxman S; Yacoub A; Dent P; Fisher PB
Oncogene; 2005 Jan; 24(4):585-96. PubMed ID: 15580305
[TBL] [Abstract][Full Text] [Related]
13. Targeting inhibition of K-ras enhances Ad.mda-7-induced growth suppression and apoptosis in mutant K-ras colorectal cancer cells.
Lebedeva IV; Su ZZ; Emdad L; Kolomeyer A; Sarkar D; Kitada S; Waxman S; Reed JC; Fisher PB
Oncogene; 2007 Feb; 26(5):733-44. PubMed ID: 16924242
[TBL] [Abstract][Full Text] [Related]
14. mda-7/IL-24 Induces Cell Death in Neuroblastoma through a Novel Mechanism Involving AIF and ATM.
Bhoopathi P; Lee N; Pradhan AK; Shen XN; Das SK; Sarkar D; Emdad L; Fisher PB
Cancer Res; 2016 Jun; 76(12):3572-82. PubMed ID: 27197168
[TBL] [Abstract][Full Text] [Related]
15. A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells.
Su Z; Lebedeva IV; Gopalkrishnan RV; Goldstein NI; Stein CA; Reed JC; Dent P; Fisher PB
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10332-7. PubMed ID: 11526239
[TBL] [Abstract][Full Text] [Related]
16. Eradication of therapy-resistant human prostate tumors using an ultrasound-guided site-specific cancer terminator virus delivery approach.
Greco A; Di Benedetto A; Howard CM; Kelly S; Nande R; Dementieva Y; Miranda M; Brunetti A; Salvatore M; Claudio L; Sarkar D; Dent P; Curiel DT; Fisher PB; Claudio PP
Mol Ther; 2010 Feb; 18(2):295-306. PubMed ID: 19888195
[TBL] [Abstract][Full Text] [Related]
17. Combining histone deacetylase inhibitors with MDA-7/IL-24 enhances killing of renal carcinoma cells.
Hamed HA; Das SK; Sokhi UK; Park MA; Cruickshanks N; Archer K; Ogretmen B; Grant S; Sarkar D; Fisher PB; Dent P
Cancer Biol Ther; 2013 Nov; 14(11):1039-49. PubMed ID: 24025359
[TBL] [Abstract][Full Text] [Related]
18. A combinatory use of adenoviruses expressing melanoma differentiation-associated gene-7 and replication-competent adenoviruses produces synergistic effects on pancreatic carcinoma cells.
Ma G; Zhong B; Okamoto S; Jiang Y; Kawamura K; Liu H; Li Q; Shingyoji M; Sekine I; Tada Y; Tatsumi K; Shimada H; Hiroshima K; Tagawa M
Tumour Biol; 2015 Sep; 36(10):8137-45. PubMed ID: 25990458
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors interact with melanoma differentiation associated-7/interleukin-24 to kill primary human glioblastoma cells.
Hamed HA; Yacoub A; Park MA; Archer K; Das SK; Sarkar D; Grant S; Fisher PB; Dent P
Mol Pharmacol; 2013 Aug; 84(2):171-81. PubMed ID: 23661648
[TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer targeted adenoviral-mediated mda-7/IL-24 gene therapy.
Mahasreshti PJ; Kataram M; Wu H; Yalavarthy LP; Carey D; Fisher PB; Chada S; Alvarez RD; Haisma HJ; Dent P; Curiel DT
Gynecol Oncol; 2006 Mar; 100(3):521-32. PubMed ID: 16225913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
